| Term 
 
        |   Beta- Andenergic Blocking Agents   -metoprolol (Toprol) -bisporlol (Zebta) -atenolol (Tenormin) -Propanolol (Inderal) |  | Definition 
 
        | MOA- Blocks Beta-1 receptors decreases HR, inhibits renin release from kidneys   Uses:Initial therapy for stage 1& 2 HTN   C.S.E- Bradycardia, masks hypoglycemia in Diabetic Patients   |  | 
        |  | 
        
        | Term 
 
        | Diuretics (Loop)   -furosemide (lasix) -metolazone (Zaroxolyn) ethacrynic acid (Edecrin) -bumetanide (Bumex) |  | Definition 
 
        | MOA- Deplets volume, sodium excretion, vasodialation of peripheral arterioles |  | 
        |  | 
        
        | Term 
 
        | Diuretics (Thiazides)   -hydrochlorothiazide   |  | Definition 
 
        | MOA- Deplets volume, sodium excretion, vasodialtaion of peripheral arterioles |  | 
        |  | 
        
        | Term 
 
        | Transdermal Contaceptives   morelgetromin-Ethinyl estradiol transdermal system   (ortho Evra)   |  | Definition 
 
        | MOA- Inhibits ovulation   Uses- estrogen and progestin in patch form   S.E-Blurred vision, leg pain |  | 
        |  | 
        
        | Term 
 
        | Oral Contraceptives   -Combination Pill   -Mini Pill   - Extended and Continuous |  | Definition 
 
        | Combintaion- taken for 21 days of menstral cycle, estrogen and progestin Subdivied - monophasic, biphasic, triphasic   Mini Pill- taken everyday - only progestin   Extended and Continuous - 24 or 84 day cycles followed by a short placebo period |  | 
        |  | 
        
        | Term 
 
        | Oral Contraceptives   -Estrogen - Blocks pituitary release of FSH   - Progestins - Inhibit Pituitary Release of LH   |  | Definition 
 
        | MOA- Induce contraception by inhibinting ovulation   S.E.- Break through bleeding, leg pain, chest pain, SOB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Common cause of lower reproduction tract infections   -candida albicans -trichomonas vaginalis - gardnerella vaginalis |  | 
        |  | 
        
        | Term 
 
        | Other Agents   Phytonadione   |  | Definition 
 
        | MOA- fat soluable vitamin K fot the production of blood clotting factors   Uses- Administered prophylactically to protect against hemorrhagic diseas of the the new born   S.E- brusing , hemorrhage |  | 
        |  | 
        
        | Term 
 
        | Other Agents   Erythromycin Ophthalmic Ointment (Ilotycin) |  | Definition 
 
        | MOA & Uses- macrolide antibiotic used prophylactically to prevent opthalmia neonatorum, effective against C. trachomatis   S.E.- mild conjunctivitis |  | 
        |  | 
        
        | Term 
 
        | Other Agnets   - Rho (D) immune globulin |  | Definition 
 
        | Suspress stimulation of actice immunity by Rh-positive foreign body cells, prevent Rh hemolytic disease in new borns   Uses- Prevent Rh immunization fo Rh- negative patient exposed to Rh- positive blood   S.E.- localized tenderness, generalized aches and pains |  | 
        |  | 
        
        | Term 
 
        | Other agents   -clomiphene citrate (Clomid) |  | Definition 
 
        | MOA- stimulate ovaries to release ova for potential fertilization   Uses- induce ovulation in woment with low estrogen levels   SE- sever abdominla cramps visual disturbance |  | 
        |  | 
        
        | Term 
 
        | Uterine relaxants   Terbutaline sulfate (Brethine) |  | Definition 
 
        | MOA - Beta 1 & 2 agonist produces telaxation of uterine , bronchial and vasculat smooth musce Increased HR   uses- STOP premature labor wehn no underlying pathology indicates pregnancy be discontinued   se- tachycardia, palpitaions, HTN |  | 
        |  | 
        
        | Term 
 
        | Uterine telaxants   -magnesium sulfate |  | Definition 
 
        | moa- anticonvulsant effect, smooth muscle, relaxation, inhibit uterine muscle contractions   uses - inhibit preterm labor, controll seizure activity, associated with preeclampsia, and eclampsia   se- confusion, decreased urine out put.   ANTIDOTE FOR MAGNESIUM TOXICITY |  | 
        |  | 
        
        | Term 
 
        | UTERINE STIMULANTS   -oxytocin (Pitocin) |  | Definition 
 
        | moa- stimulats uterine smooth muscle, blood vessels, mammary glands   uses - initiate active labor in 3rd trimester, postpartum uterine atony controll, and hemorrhage   se- hypotension, HTN, H2O intocicaiton, dehydration, hemorrhage |  | 
        |  | 
        
        | Term 
 
        | Uterine stimlants   -ergonovine (Ergotrate meleate)   -methylergonovine (Methergine) |  | Definition 
 
        | moa- Directly simulate uterine contractions   uses controll bleeding and maintain firmness in postpartum patients   SE- HTN |  | 
        |  | 
        
        | Term 
 
        | Uterine stimulants   -misprostol (Cytotec) |  | Definition 
 
        | moa- causes uterine contraction in pregnancy   uses - cervical ripening agent, induce labor, serious postpatum hemorrhage   se- orthostatic hypotension |  | 
        |  | 
        
        | Term 
 
        | uterine stimulants   -Dinoprostone (prostin E2, Prepidil, Cervidil) |  | Definition 
 
        | MOA- uterine and GI smooth muscle stimulant, start and contunue cervical ripening at term   uses- expell uterine contents after fetal death,   se- orthostatic hypotension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | implementation of fertilized ovum, continuation of pregnancy, brepares breats for lactation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | breast, voice quality, broard pelvis and menstruation development |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antiandrogen Agents   -Dutastride (Avodart)   -Finasteride (Proscar)   |  | Definition 
 
        | moa- inhibie enxyme 5-alpha reductase lowers DHT levels   uses - Treats BPH, reduces risk of urinary retention and reduces the need for surgery in BPH patients   SE- impotence, decreased libido and volume of ejaculate   FINASTERIDE - S.E.- male pattern baldness |  | 
        |  | 
        
        | Term 
 
        | Alpha-1 Andernergic Blocking agents   -Terasozin   -Tamsulosin (Flomax) |  | Definition 
 
        | moa- block alpha-1 receptors of the prostate gland, muscle relaxing , increases outflow   uses- reduce mild to moderate urinary obstruction in men w/BPH   se- tachycardia, fainting |  | 
        |  | 
        
        | Term 
 
        | Phosphodiesterase Inhibitors   -sildenafil (Viagra)   - tadafil (Cialis)   - vardenafil (Levitra)   |  | Definition 
 
        | moa- selectice inhibitor of PDE-5 enzyme   Uses- erectile dysfunction, pulmonayr arterial hypertension   Se- hypotension, sustained erection, loss of vistion |  | 
        |  | 
        
        | Term 
 
        | Direct Renin Inhibitors   -aliskiren (Tekturna) |  | Definition 
 
        | moa- block 1st step in RAAS cascade prevention release of aldosterone   uses- antihypertensive, reduce B/P   SE - altered fluid and electrlytes, Birth defects |  | 
        |  | 
        
        | Term 
 
        | ARBs (angiotensin receptor blockers)   -valsartan (Diovan) - Olmesartan (Benicar) -losartan (Cozaar)   |  | Definition 
 
        | moa- binds to angiotensin 2 receptor sites and block the vasoconstrictor from binding to receptor sites in targes organs   Uses- reduce B/P   se- hyperkalemia, birth defects |  | 
        |  | 
        
        | Term 
 
        | Intrabaginal Hormonal Contraceptive   etonogestrel-ethinyl estradiol vaginal ring (Nuva Ring) |  | Definition 
 
        | MOA- Estrogen and progestin inhibit ovulation   uses - plastic ring dosage form instered into vagina   se- leg pain, chest pain, SOB |  | 
        |  | 
        
        | Term 
 
        | ACE Inhibitors (angiotensin converting enzyme)   -lisinopril (Privinil) -catopril -enalapril (Vasotec) -ramipril (Altace) |  | Definition 
 
        | moa- inhibit angiotensin I convering enzyme disrupting the conversion. ACE I-> ACE II   uses- single therapy for stage 1 or 2 htn   se- COUGH |  | 
        |  | 
        
        | Term 
 
        | Miscellaneous Antilipemic Agents   -omega - 3 fatty acids (Lovaza) |  | Definition 
 
        | moa- decrease synthesis of triglycerides in liver ACTIVE INGREDIENTS OF EPA AND DHA   USES- combo treatment w/ dietary therapy to decrease the increase of triglyceride levels   se- back and abdominal pain |  | 
        |  | 
        
        | Term 
 
        | Miscellaneous Antilipmic Agents   -ezetimibe (Zetia) |  | Definition 
 
        | moa- block absorption of cholestrole from small intestine   uses - combo treatment w/ dietary therapy to decrease increased chloesterol   se- abdominal pain   SHOULD BE USED IN COMBO |  | 
        |  | 
        
        | Term 
 
        | Fibric acids   -Gemfibrozil (Lopid)   -Fenofibrate (Tricor)   |  | Definition 
 
        | moa- decrease triglyceride levels   uses- combo treatment with dietary therapy to treat hypertriglyceridemia   S E -malaise, jaundice |  | 
        |  | 
        
        | Term 
 
        | HMG-CoA reductase Inhibitors (Statins)  -Tosuvastatin (Crestor) -Atorcastatin (Lipitor) -Simvastatin (Zocor)   |  | Definition 
 
        | moa- inhibit enzymes responsible for converting HMG-CoA to mevalonate, decrease liver cholesterol   uses- combo w/ diatary therapy to decrease LDL and total cholestrol levels   SE- liver dysfuction, myoapthy, RHABDOMYOLYSIS   Pregnancy category X   |  | 
        |  | 
        
        | Term 
 
        | NIACIN (NICOTINC ACID) Vit B3     |  | Definition 
 
        | moa- inhibits VLDL synthesis by liver cells Best to increase HDL   uses - treatment of dyslipidemies, lower risk of CAD   SE- Hepato tozicity , myopathy, HTN DO NOT GIVE IN PEPTIC ULCER DISEASE |  | 
        |  | 
        
        | Term 
 
        | Bil Acid - Binding Resins   -Cholestyramin -Colestipol -Colesevelum   MUST BE GIVEN WITH MEALS    |  | Definition 
 
        | MOA- Binds to bile acids, promotes increased metabolism of cholesterol   uses - in combo with dietary therapy to decrease increased cholesterol   SE - constipation, Vit K deficiency  |  | 
        |  | 
        
        | Term 
 
        | Directy Vasodilator   -Hydralazine (Apersolin) -Minoxidil (Loniten) -Nitroprusside (Nitropress) |  | Definition 
 
        | moa- relax arteriel smooth muscle, decrease peripheral bascular resistance   uses - treats stage 2 HTN, renal disease HTN   SE - palpitation, tachycardia, Hair growth |  | 
        |  | 
        
        | Term 
 
        | Central - Acting Alpha-2 Agnoists   -Clonidine (Catapress) -Methyldopa |  | Definition 
 
        | moa- stimulats alpha-adernergic recptors in the brainstem, reducing sympathetic out flow from the CNS   uses- used only in combination   SE- Depression, Rash |  | 
        |  | 
        
        | Term 
 
        | Alpha-1 Adrenergic Blocking Agents   -doxasozin (cardura) -prazosin (Minipress) -Terazosin (Hytin)   |  | Definition 
 
        | moa - block postsynaptic alpha-1 receptors to produce vasodialation, decrease peripheral vascular resistance   uses- decrease B/P, Decreas mild to moderate urinay obstruction (BPH in men)   SE- tachycardia, dizziness |  | 
        |  | 
        
        | Term 
 
        | Calcium Channel Blockers DIHYDROPYRIDINES   -amlodipine (Norvasc) -bepridil (Cascor) -felodipine (Plendil)   |  | Definition 
 
        | moa- dilates the arteris   Uses- HTN, A-FIB   SE- Hypotension, syncope, edema |  | 
        |  | 
        
        | Term 
 
        | Calcium Channel Blockers NONDIYDROPYRIDINES   -diltiazem (Cardizem) -verapamil (Calan) |  | Definition 
 
        | moa - inhibits the transportation of Calcium in to the myocardial and casculat smooth muscle reduces mycardial comtractabily and demant for oxygen   Uses- A-FIB, 1st or 2nd line of HTN   SE- Hypotension, syncope, edema |  | 
        |  |